Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Active, not recruiting Observational

the Thickness of the Muscles and Pain in Impingement Syndrome

NCT06665139 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2024-09-01
Last updated
2024-10-30

Condition(s) studied

Impingement ShoulderImpingement SyndromePain, Shoulder

Investigational drug(s) / intervention(s)

muscle thickness

muscle thickness: Pain intensity will be measured with visual analog scale, sonographic severity grade of shoulder impingement syndrome, muscle thickness of serratus anterior muscle, upper trapezius and middle trapezius with USG in patients diagnosed with impingement and meeting the criteria and healthy volunteers.

Study summary

Pain intensity will be measured with visual analog scale. Sonographic severity grade of shoulder impingement syndrome, serratus anterior muscle, upper trapezius and middle trapezius will be measured with USG in patients diagnosed with impingement and meeting the criteria and healthy volunteers.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * 18-65 years * Cognitive ability to understand test instructions * Symptom duration longer than 1 month * At least two positive Neer, Hawkins and painful arch tests for healty volunteers * 18-65 years * cognitive ability to understand test instructions * negative impingment test Exclusion Criteria: * Fibromyalgia * cervical radiculopathy * those who have received injections or physical therapy in the last month * Those with a disorder that may affect shoulder joint range of motion and muscle mass (previous fracture, surgery, subluxation) * BMI over 35 * inflammatory disease

Primary outcome measure(s)

  • sonographic severity grade of shoulder impingment syndrome — baseline
    The distance between the acromion and the greater tuberosity will be measured in both neutral and dynamic positions, and the disease severity will be assessed according to the ratio between these two data.

Trial sites (1)

FacilityCityRegionStatus
Cansın Medin Ceylan Istanbul Bahcelievler
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06665139 on ClinicalTrials.gov ↗ ← All trials in Turkey